Market Resilience: Alignment Healthcare Inc (ALHC) Finishes Weak at 9.00, Down -4.36

For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Alignment Healthcare Inc (NASDAQ: ALHC) closed the day trading at $9.00 down -4.36% from the previous closing price of $9.41. In other words, the price has decreased by -$4.36 from its previous closing price. On the day, 1.03 million shares were traded. ALHC stock price reached its highest trading level at $9.38 during the session, while it also had its lowest trading level at $8.975.

Ratios:

For a better understanding of ALHC, let’s look at its different ratios. In the meantime, Its Debt-to-Equity ratio is 1.78 whereas as Long-Term Debt/Eq ratio is at 1.78.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, BofA Securities on May 30, 2024, Upgraded its rating to Buy and sets its target price to $11 from $7.75 previously.

On May 30, 2024, Robert W. Baird started tracking the stock assigning a Outperform rating and target price of $10.

Piper Sandler Upgraded its Neutral to Overweight on May 08, 2024, whereas the target price for the stock was revised from $6 to $8.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Sep 05 ’24 when JOYCE CHRISTOPHER J sold 4,541 shares for $10.00 per share. The transaction valued at 45,422 led to the insider holds 399,738 shares of the business.

JOYCE CHRISTOPHER J sold 1,300 shares of ALHC for $13,000 on Sep 04 ’24. The Chief Legal and Admin. Officer now owns 404,279 shares after completing the transaction at $10.00 per share. On Sep 05 ’24, another insider, Freeman Robert Thomas, who serves as the Chief Financial Officer of the company, sold 4,789 shares for $10.00 each. As a result, the insider received 47,913 and left with 407,990 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ALHC now has a Market Capitalization of 1721699968 and an Enterprise Value of 1579005568. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.77 while its Price-to-Book (P/B) ratio in mrq is 13.91. Its current Enterprise Value per Revenue stands at 0.707 whereas that against EBITDA is -15.103.

Stock Price History:

Over the past 52 weeks, ALHC has reached a high of $10.16, while it has fallen to a 52-week low of $4.46. The 50-Day Moving Average of the stock is 1.19%, while the 200-Day Moving Average is calculated to be 23.79%.

Shares Statistics:

Over the past 3-months, ALHC traded about 900.24K shares per day on average, while over the past 10 days, ALHC traded about 690760 shares per day. A total of 188.95M shares are outstanding, with a floating share count of 89.07M. Insiders hold about 53.44% of the company’s shares, while institutions hold 41.07% stake in the company. Shares short for ALHC as of 1723680000 were 4653862 with a Short Ratio of 5.17, compared to 1721001600 on 4325700. Therefore, it implies a Short% of Shares Outstanding of 4653862 and a Short% of Float of 3.8.

Most Popular